Open AccessSAT-100 Trial-in-Progress: ZEPHYR, a Pivotal Phase 2b/3 Randomized, Placebo-Controlled Study of Livoletide, a Novel Unacylated Ghrelin Analog, for the Treatment of Hyperphagia and Food-Related Behaviors in Patients with Prader-Willi Syndrome
Author(s) -
Soraya Allas,
Pharis Mohideen,
Thomas Delale,
Vivian Lin,
Nadege Tremel,
Michael Yeh,
M. Tauber
Publication year - 2019
Publication title -
journal of the endocrine society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.046
H-Index - 20
ISSN - 2472-1972
DOI - 10.1210/js.2019-sat-100
Subject(s) - orexigenic , placebo , ghrelin , medicine , adverse effect , randomized controlled trial , endocrine system , hormone , pathology , receptor , alternative medicine , neuropeptide y receptor , neuropeptide
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom